These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 1353505)

  • 1. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
    Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
    J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.
    Bertherat J; Chanson P; Dewailly D; Dupuy M; Jaquet P; Peillon F; Epelbaum J
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1577-83. PubMed ID: 7903312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas.
    Moyse E; Le Dafniet M; Epelbaum J; Pagesy P; Peillon F; Kordon C; Enjalbert A
    J Clin Endocrinol Metab; 1985 Jul; 61(1):98-103. PubMed ID: 2860120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090).
    Faglia G; Bazzoni N; Spada A; Arosio M; Ambrosi B; Spinelli F; Sara R; Bonino C; Lunghi F
    J Clin Endocrinol Metab; 1991 Oct; 73(4):850-6. PubMed ID: 1653785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog.
    Bertherat J; Chanson P; Dewailly D; Enjalbert A; Jaquet P; Kordon C; Peillon F; Timsit J; Epelbaum J
    Horm Res; 1992; 38(1-2):94-9. PubMed ID: 1306525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin receptors on pituitary somatotrophs, thyrotrophs, and lactotrophs: pharmacological evidence for loose coupling to adenylate cyclase.
    Epelbaum J; Enjalbert A; Krantic S; Musset F; Bertrand P; Rasolonjanahary R; Shu C; Kordon C
    Endocrinology; 1987 Dec; 121(6):2177-85. PubMed ID: 2890515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific somatostatin receptors on human pituitary adenoma cell membranes.
    Ikuyama S; Nawata H; Kato K; Karashima T; Ibayashi H; Nakagaki H
    J Clin Endocrinol Metab; 1985 Oct; 61(4):666-71. PubMed ID: 2863281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P; Arlot S; Bauters C; Chanson P; Kuhn JM; Pugeat M; Marechaud R; Teutsch C; Vidal E; Sassano P
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Medical Treatment of Thyrotropin-Secreting Pituitary Adenomas by First-Generation Somatostatin Analogs: A Case Study of Seven Patients.
    Rimareix F; Grunenwald S; Vezzosi D; Rivière LD; Bennet A; Caron P
    Thyroid; 2015 Aug; 25(8):877-82. PubMed ID: 26244412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
    Sanno N; Teramoto A; Matsuno A; Takekoshi S; Osamura RY
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2518-22. PubMed ID: 7543115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
    Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
    Teramoto A; Sanno N; Tahara S; Osamura YR
    Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of somatostatin receptors negatively coupled to adenylate cyclase in ectopic growth hormone-releasing hormone- and alpha-subunit-secreting tumors from acromegalic patients responsive to octreotide.
    Bertherat J; Turpin G; Rauch C; Li JY; Epelbaum J; Sassolas G; Schaison G
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1457-64. PubMed ID: 7962343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status.
    Reubi JC; Landolt AM
    J Clin Endocrinol Metab; 1989 Apr; 68(4):844-50. PubMed ID: 2537844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses.
    Reubi JC; Heitz PU; Landolt AM
    J Clin Endocrinol Metab; 1987 Jul; 65(1):65-73. PubMed ID: 3034958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
    Boni G; Ferdeghini M; Bellina CR; Matteucci F; Castro Lopez E; Parenti G; Canapicchi R; Bianchi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells.
    Hofland LJ; van Koetsveld PM; Wouters N; Waaijers M; Reubi JC; Lamberts SW
    Endocrinology; 1992 Aug; 131(2):571-7. PubMed ID: 1322274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro.
    Tulipano G; Bonfanti C; Milani G; Billeci B; Bollati A; Cozzi R; Maira G; Murphy WA; Poiesi C; Turazzi S; Giustina A
    Neuroendocrinology; 2001 May; 73(5):344-51. PubMed ID: 11399907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and alpha-subunit: evidence for secretion of TSH with increased bioactivity.
    Beck-Peccoz P; Piscitelli G; Amr S; Ballabio M; Bassetti M; Giannattasio G; Spada A; Nissim M; Weintraub BD; Faglia G
    J Clin Endocrinol Metab; 1986 Apr; 62(4):704-11. PubMed ID: 2419356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
    Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.